PL1896022T3 - Nowa kompozycja farmaceutyczna i jej zastosowanie w sposobie leczenia pacjentów z przekrwieniem śluzówki górnych dróg oddechowych - Google Patents

Nowa kompozycja farmaceutyczna i jej zastosowanie w sposobie leczenia pacjentów z przekrwieniem śluzówki górnych dróg oddechowych

Info

Publication number
PL1896022T3
PL1896022T3 PL05757506T PL05757506T PL1896022T3 PL 1896022 T3 PL1896022 T3 PL 1896022T3 PL 05757506 T PL05757506 T PL 05757506T PL 05757506 T PL05757506 T PL 05757506T PL 1896022 T3 PL1896022 T3 PL 1896022T3
Authority
PL
Poland
Prior art keywords
patients
treatment
pharmaceutical composition
upper respiratory
novel pharmaceutical
Prior art date
Application number
PL05757506T
Other languages
English (en)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of PL1896022T3 publication Critical patent/PL1896022T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05757506T 2005-06-17 2005-06-17 Nowa kompozycja farmaceutyczna i jej zastosowanie w sposobie leczenia pacjentów z przekrwieniem śluzówki górnych dróg oddechowych PL1896022T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NZ2005/000132 WO2006135254A1 (en) 2005-06-17 2005-06-17 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
EP05757506A EP1896022B1 (en) 2005-06-17 2005-06-17 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion

Publications (1)

Publication Number Publication Date
PL1896022T3 true PL1896022T3 (pl) 2013-03-29

Family

ID=37532532

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05757506T PL1896022T3 (pl) 2005-06-17 2005-06-17 Nowa kompozycja farmaceutyczna i jej zastosowanie w sposobie leczenia pacjentów z przekrwieniem śluzówki górnych dróg oddechowych

Country Status (9)

Country Link
US (2) US8603523B2 (pl)
EP (1) EP1896022B1 (pl)
AU (2) AU2005333081B2 (pl)
CA (1) CA2612179C (pl)
ES (1) ES2398960T3 (pl)
MX (1) MX2007016065A (pl)
NZ (3) NZ588134A (pl)
PL (1) PL1896022T3 (pl)
WO (1) WO2006135254A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
US10130627B2 (en) 2008-12-19 2018-11-20 GlaxoSmithKine Consumer Healthcare S.A. Phenylephrine formulations with improved stability
EP2379057B1 (en) * 2008-12-19 2013-07-17 Novartis AG Phenylephrine formulations with improved stability
US20110104273A1 (en) * 2009-11-05 2011-05-05 Depomed, Inc. Gastric retentive pharmaceutical compositions for immediate and extended release of phenylephrine
US11213480B1 (en) 2015-08-06 2022-01-04 Hikma Pharmaceuticals International Limited Phenylephrine hydrochloride ready-to-use solution
MX391125B (es) * 2017-01-26 2025-03-21 Laboratorios Liomont S A De C V Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US5616578A (en) * 1993-08-26 1997-04-01 The Dupont Merck Pharmaceutical Company Method of treating human immunodeficiency virus infection using a cyclic protease inhibitor in combination with a reverse transcriptase inhibitor
US5478858A (en) 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
EP0941091A1 (en) 1996-10-31 1999-09-15 Schering Corporation Composition, for the treatment of asthma, containing loratadine and a decongestant
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
PE20020055A1 (es) * 2000-05-25 2002-02-12 Schering Corp Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
KR20040002976A (ko) * 2001-05-18 2004-01-07 랜박시 래보러터리스 리미티드 옥스카르바제핀 제형
WO2003089007A1 (en) * 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
RU2220740C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Средство для лечения аллергического ринита и аллергического конъюнктивита
WO2004023984A2 (en) 2002-09-13 2004-03-25 Smith C Steven Novel composition and method for treatment of upper respiratory conditions
JP2006525308A (ja) * 2003-05-02 2006-11-09 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー 耐熱性および耐湿性が改善された変性デンプンを含有する速溶性の経口消耗フィルム
US20050096390A1 (en) * 2003-10-10 2005-05-05 Per Holm Compositions comprising fenofibrate and pravastatin
AU2005315291A1 (en) * 2004-12-13 2006-06-22 Mcneil-Ppc, Inc. Compositions and methods for stabilizing active pharmaceutical ingredients

Also Published As

Publication number Publication date
EP1896022A4 (en) 2008-08-06
CA2612179C (en) 2016-08-02
US20090203727A1 (en) 2009-08-13
AU2005333081A1 (en) 2006-12-21
US8603523B2 (en) 2013-12-10
WO2006135254A1 (en) 2006-12-21
NZ575838A (en) 2010-10-29
US20090215811A1 (en) 2009-08-27
NZ588134A (en) 2010-11-26
NZ541960A (en) 2010-01-29
AU2005333081B2 (en) 2010-06-24
AU2009201201A1 (en) 2009-04-30
EP1896022B1 (en) 2012-10-31
MX2007016065A (es) 2008-03-10
HK1112407A1 (en) 2008-09-05
ES2398960T3 (es) 2013-03-22
CA2612179A1 (en) 2006-12-21
EP1896022A1 (en) 2008-03-12

Similar Documents

Publication Publication Date Title
IL195947A (en) Manicured cyclic compounds and pharmaceutical preparations containing them for use @ for prevention @ and treatment @ for diabetes
ZA200710387B (en) Method and composition for use in preparation of a patient for surgery
IL200278A (en) Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness
IL197420A (en) Polymorphic form of 4 - [3 - (4 - cyclopropanecarbonyl - piperazine - 1 - carbonyl) - 4 - fluoro - benzyl] - h2 - phthalazine - 1 - on, methods of preparation, a pharmaceutical preparation containing it and uses in this form to prepare drugs for the treatment of the human body
IL178038A (en) Delayed-release oral dosage forms for pain management
PL1601397T3 (pl) Ulepszenia odnoszące się do mechanizmów napędowych odpowiednich do stosowania w urządzeniach do podawania leków
SI1601396T2 (sl) Izboljšave v pogonskih mehanizmih, ki so primerni za uporabo v napravah za dajanje zdravila, in v zvezi z njimi
EP1827391A4 (en) DOSAGE FORMS AND METHODS OF USE THEREOF
IL226562A0 (en) Pharmacy combinations containing benzoxazine for the treatment of respiratory diseases
GB0523576D0 (en) Drug composition and its use in therapy
IL205290A (en) A variant of human neurorthin protein, or its active biological part, containing medicinal preparations, and its use in the preparation of therapeutic drugs
IL182356A0 (en) Novel cyclic and acyclic propenones and their use in the preparation of medicaments for treating cns disorders
LT2340872T (lt) Naujos farmacinės kompozicijos, naudingos nemigos gydyme
EP1954800A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
EP1928247A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
ZA200800469B (en) Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
EP1945171A4 (en) MANUFACTURE OF A MEDICAL DEVICE AND USE IN ALTERNATIVE MEDICINE FOR REHABILITATION TREATMENT OF CHRONIC DISEASES
HU0500516D0 (en) Medicinal materials of natural origin, their use, process and device for treatment of osteoporosis
EP1968481A4 (en) DEVICE AND DISTRIBUTION OF MEDICINALLY PURE OXYGEN
GB0406014D0 (en) Pharmaceutical composition and use
PL1877035T3 (pl) Kompozycja farmaceutyczna i postać galenowa szybko rozpadająca się w jamie ustnej oraz sposób jej wytwarzania
PL1764097T3 (pl) Sposoby i kompozycje kojące tkanki jamy ustnej i nosa
GB2414682B (en) Improvements relating to medical respiratory apparatus
PL383271A1 (pl) Kompozycja farmaceutyczna przydatna w leczeniu chorób wirusowych
PL383272A1 (pl) Kompozycja farmaceutyczna przydatna w leczeniu chorób wirusowych